SCHEMBL30492736

SCHEMBL30492736

CC1CN(C(=O)C(Cl)Cl)C2(COC2)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8429253 0.79 SMN1; SMN2 (0.34)
SCHEMBL8429251 0.79 SMN1; SMN2 (0.34)
SCHEMBL167473 0.79 SMN1; SMN2 (0.34)
SCHEMBL9506387 0.74 SMN1; SMN2 (0.31)
SCHEMBL5603396 0.68 CTSB (0.32)
SCHEMBL30492776 0.67
SCHEMBL11347845 0.63
SCHEMBL11435287 0.63
SCHEMBL8852486 0.62
SCHEMBL9507715 0.62 MEN1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116284025-A Spiro heterocyclic compound with anticancer effect, pharmaceutical composition and application thereof 国科大杭州高等研究院 2023-06-23 CN disclosed